CN114190551A - 一种具有改善睡眠作用的组合物 - Google Patents
一种具有改善睡眠作用的组合物 Download PDFInfo
- Publication number
- CN114190551A CN114190551A CN202111623830.6A CN202111623830A CN114190551A CN 114190551 A CN114190551 A CN 114190551A CN 202111623830 A CN202111623830 A CN 202111623830A CN 114190551 A CN114190551 A CN 114190551A
- Authority
- CN
- China
- Prior art keywords
- parts
- sleep
- composition
- mice
- improving effect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000007958 sleep Effects 0.000 title claims abstract description 35
- 239000000203 mixture Substances 0.000 title claims abstract description 28
- 230000000694 effects Effects 0.000 title claims description 21
- 241000304195 Salvia miltiorrhiza Species 0.000 claims abstract description 12
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims abstract description 12
- 241001080798 Polygala tenuifolia Species 0.000 claims abstract description 11
- 244000197580 Poria cocos Species 0.000 claims abstract description 11
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 11
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 7
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 7
- 235000013361 beverage Nutrition 0.000 claims description 29
- 239000003814 drug Substances 0.000 claims description 5
- 235000009508 confectionery Nutrition 0.000 claims description 4
- 235000013305 food Nutrition 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 239000002674 ointment Substances 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 3
- 230000003860 sleep quality Effects 0.000 abstract description 2
- 239000007787 solid Substances 0.000 description 26
- 241000699670 Mus sp. Species 0.000 description 22
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 17
- 241001465754 Metazoa Species 0.000 description 14
- 230000004620 sleep latency Effects 0.000 description 14
- 229960001412 pentobarbital Drugs 0.000 description 13
- 230000004622 sleep time Effects 0.000 description 13
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 12
- 206010022437 insomnia Diseases 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 7
- 230000028527 righting reflex Effects 0.000 description 7
- 238000003304 gavage Methods 0.000 description 6
- 230000000147 hypnotic effect Effects 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 244000131316 Panax pseudoginseng Species 0.000 description 5
- 235000003181 Panax pseudoginseng Nutrition 0.000 description 5
- 229940125717 barbiturate Drugs 0.000 description 5
- HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical compound O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 description 5
- 230000008034 disappearance Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 229960002275 pentobarbital sodium Drugs 0.000 description 4
- 230000002035 prolonged effect Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 210000000582 semen Anatomy 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- 230000002936 tranquilizing effect Effects 0.000 description 3
- YTFVRYKNXDADBI-UHFFFAOYSA-N 3,4,5-trimethoxycinnamic acid Chemical compound COC1=CC(C=CC(O)=O)=CC(OC)=C1OC YTFVRYKNXDADBI-UHFFFAOYSA-N 0.000 description 2
- 208000000044 Amnesia Diseases 0.000 description 2
- 208000031091 Amnestic disease Diseases 0.000 description 2
- 206010008479 Chest Pain Diseases 0.000 description 2
- 206010024264 Lethargy Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 230000006986 amnesia Effects 0.000 description 2
- 229960000796 barbital sodium Drugs 0.000 description 2
- FTOAOBMCPZCFFF-UHFFFAOYSA-N barbitone sodium Natural products CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- -1 diterpene compound Chemical class 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 208000019116 sleep disease Diseases 0.000 description 2
- 230000036578 sleeping time Effects 0.000 description 2
- RGHFKWPGWBFQLN-UHFFFAOYSA-M sodium;5,5-diethylpyrimidin-3-ide-2,4,6-trione Chemical compound [Na+].CCC1(CC)C([O-])=NC(=O)NC1=O RGHFKWPGWBFQLN-UHFFFAOYSA-M 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- HRYZPBSOAMTFEL-UHFFFAOYSA-N 1,3-diazinane-2,4,6-trione;sodium Chemical compound [Na].O=C1CC(=O)NC(=O)N1 HRYZPBSOAMTFEL-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 235000001188 Peltandra virginica Nutrition 0.000 description 1
- 241000208966 Polygala Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 208000010340 Sleep Deprivation Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- OORMXZNMRWBSTK-LGFJJATJSA-N dammarane Chemical compound C1CCC(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@H]([C@H](C)CCCC(C)C)[C@H]4CC[C@@H]3[C@]21C OORMXZNMRWBSTK-LGFJJATJSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229930004069 diterpene Natural products 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000000517 effect on sleep Effects 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000012372 quality testing Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- MHQHHBYRYFICDV-UHFFFAOYSA-M sodium;pyrimidin-3-ide-2,4,6-trione Chemical compound [Na+].O=C1CC(=O)[N-]C(=O)N1 MHQHHBYRYFICDV-UHFFFAOYSA-M 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 150000008130 triterpenoid saponins Chemical class 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Botany (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Inorganic Chemistry (AREA)
- Anesthesiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种具有改善睡眠作用的组合物,包括酸枣仁、茯苓、远志、丹参、三七茎叶,所述的组合物各成分重量配比为酸枣仁1‑24份,茯苓1‑24份,远志1‑12份,丹参1‑24份,三七茎叶1‑12份。该组合物能够提高人们的睡眠质量,从而使人体更加健康强壮。
Description
技术领域
本发明属于保健食品技术领域,具体涉及一种具有改善睡眠作用的组合物。
背景技术
健康的体魄来自睡眠,失眠通常指患者对睡眠时间和(或)质量不满足并影响白天社会功能的一种主观体验,主要表现为睡眠时间、深度不足,轻者入睡困难,或寐而不酣,时寐时醒或醒后不能再寐,重者则彻夜不眠,是一种神经及精神内科常见病。长期睡眠不足,将导致大脑疲劳,学习和工作效率大大下降,还会损坏记忆力、决策力及思想集中的能力。
随着现代生活节奏的加快及生活方式的改变,失眠日益成为突出的医疗及公共卫生问题,越来越多的人受到睡眠不足甚至失眠的困扰。据世界卫生组织调查资料显示,全球至少有27%以上的人有睡眠问题,1/3以上有不同程度的失眠症状,其中美国失眠发生率为32%~35%,英国为10%~14%,日本为20%。在我国,估计患病率至少大于10%,即1.3亿人以上。北京朝阳医院睡眠呼吸中心发布的《2018中国睡眠质量调查报告》,其中对10万人进行了调查,调查对象覆盖全国所有省份,调查结果显示,16%的被调查者存在夜间睡眠时间不足6个小时,表现为24点以后才上床睡觉,并且在6点之前起床;有83.81%的被调查者经常受到睡眠问题困扰,其中入睡困难占25.83%,浅睡眠者有26.49%。
截至目前,我国睡眠产业市场容量已经达到千亿元,目前市面的很多改善睡眠的产品达不到预期的效果,因此,发明一款使用传统中药为原料的具有改善睡眠功能的保健食品具有较好的现实意义和社会价值。
发明内容
本发明的目的在于提供一种具有改善睡眠作用的组合物,该组合物中的各种成分合理组方、配合共用,通过多种途径、多层次达到改善睡眠的保健作用。
本发明提供的具有改善睡眠作用的组合物中各成分重量配比为:酸枣仁1-24份,茯苓1-24份,远志1-12份,丹参1-24份,三七茎叶1-12份。
制备本发明组合物中各组分的优选重量配比为:酸枣仁2-16份,茯苓2-16份,远志2-6份,丹参3-18份,三七茎叶2-6份。
制备本发明组合物中各组分的最佳重量配比为:酸枣仁8份,茯苓8份,远志3份,丹参6份,三七茎叶3份。
上述具有改善睡眠作用的组合物可制成颗粒剂、胶囊剂、片剂、口服液、药膏以及压片糖果、饮料类食品。
上述组分中酸枣仁含有丰富的总皂苷、总黄酮、总生物碱等发挥镇静催眠作用的主要活性成分,具有养心补肝、宁心安神、敛汗、生津之功效。远志具有丰富的皂苷、远志糖酯A、远志糖酯C以及TMCA等活性成分,临床上广泛用于治疗心神不安、失眠、健忘、神经衰弱。茯苓含有丰富的茯苓多糖,通利水道、渗泄水湿,既能益心脾而宁心,又能交心肾而安神,主要用于心悸怔忡、失眠健忘。丹参的有效成分为脂溶性的二萜化合物和水溶性的酚酸类化合物,具有凉血安神、活血化瘀之功效。现代学药理研究证实丹参具有抑制血小板粘附、抗凝、聚集和钙拮抗的作用,能清除氧自由基,能有效降低细胞聚集的指数,调节血液的粘稠度,增加脑部供血,缓解由于失眠所产生的症状。三七茎叶富含活性成分三七茎叶皂苷(属达玛烷型三萜皂苷),有益气安神、活血止痛之功效,用于心气不足、心血瘀阻所致的心悸、失眠、胸痛、胸闷等症。
具体实施方式
下面结合实施例对本发明作进一步阐述,以下实施方式只以举例的方式描述本发明。
实施例1:
本发明组合物中各组分的重量配比为:酸枣仁1份,茯苓1份,远志1份,丹参1份,三七茎叶1份。
实施例2:
本发明组合物中各组分的重量配比为:酸枣仁8份,茯苓8份,远志3份,丹参6份,三七茎叶3份。
实施例3:
本发明组合物中各组分的重量配比为:酸枣仁10份,茯苓10份,远志5份,丹参4份,三七茎叶4份。
实施例4:
本发明组合物中各组分的重量配比为:酸枣仁6份,茯苓6份,远志4份,丹参6份,三七茎叶3份。
实施例5:
本发明组合物中各组分的重量配比为:酸枣仁24份,茯苓24份,远志12份,丹参24份,三七茎叶12份。
以上实施例中,各组分可通过常规工艺可制成颗粒剂、胶囊剂、片剂、口服液、药膏以及压片糖果、饮料类食品。
实施例6:对小鼠的缓解体力疲劳的影响
6.1实验材料
组合物为根据实施例3的配比制备的固体饮料;酸枣仁单方饮片为酸枣仁饮片水提取物。
实验仪器:分析天平(赛多利斯科学仪器(北京)有限公司);电子秤(宁波金之展衡量仪器有限公司);超声波清洗器(上海科导超声仪器有限公司);温湿度表(衡水沈拓仪器仪表有限公司);注射器(陕西龙康鑫医疗器械有限公司)。
实验动物:选择SPF级健康雄性Balb/c小鼠(6~8周,20±20g)进行试验。购于湖南斯莱克景达实验动物有限公司,质量检测单位:湖南斯莱克景达实验动物有限公司,实验单位使用许可证编号:SYXK(滇)K2011-0011,动物许可证号:SCXK(湘)2019-0004。
6.2动物分组
适应性喂养一周后,根据体重随机分为三个大组,分组前,各实验组大鼠体质量均无统计学差异。其中第一组进行延长戊巴比妥钠睡眠时间实验,第二组进行戊巴比妥钠阈下剂量催眠实验,第三组进行巴比妥钠睡眠潜伏期实验,以上实验同时进行直接睡眠实验。每组内的小鼠随机分为空白对照组,固体饮料低、中、高剂量组。
固体饮料低剂量6.5g/kg,固体饮料中剂量13g/kg,固体饮料高剂量19.5g/kg。固体饮料以每日6.5g/kg、13g/kg、19.5g/kg·bw3个剂量组给予灌胃,分别相当于受试物人体剂量的5、10、15倍,另设置生理盐水作为空白对照组样品,受试物每日生理盐水配置,低剂量组每日灌胃1次,中、高剂量组每日灌胃2次,每3天测量一次小鼠体重,调整灌胃剂量。因鼠类活动夜间比白天活跃,因此动物干预时间在夜间7点开始。中、高剂量组每日灌胃时间为早上9:00,晚上19:00。
6.3直接睡眠实验
末次给予受试物后,观察灌胃后30min内,小鼠是否出现睡眠现象,以小鼠的翻正反射消失超过60s判为进入睡眠,翻正反射恢复即为动物觉醒。比较对照组、固体饮料各剂量组对小鼠直接催眠的影响。
实验结果表明,不同固体饮料剂量组灌胃后,均无直接出现睡眠现象,表明该固体饮料对小鼠无明显直接催眠作用。
6.4延长戊巴比妥钠睡眠时间实验
末次给予受试药物12h禁食不禁水,末次灌胃30min后,各组小鼠给予45mg/kg·bw戊巴比妥钠,注射量为0.1mL/10g·bw。以小鼠的翻正反射消失60s以上为入睡判断标准,以动物注射戊巴比妥钠到翻正反射消失的时间为睡眠潜伏期,动物翻正反射消失到恢复这段时间为动物睡眠时间,比较各受试物能否缩短戊巴比妥钠注射小鼠的入睡潜伏期,延长睡眠时间。睡眠时间延长,则说明受试物与戊巴比妥钠有协同作用。
固体饮料对巴比妥钠睡眠时间的影响见表1,由表1可以看出,空白对照组小鼠睡眠时间为(57.35±15.19)min,酸枣仁饮片组(5g/kg bw)、固体饮料低、中、高剂量组(6.5、13、19.5g/kg bw)进行干预后,小鼠的睡眠时间为(80.25±20.09)、(81.80±17.18)、(88.37±22.10)、(88.06±14.81)min。与空白对照组相比,酸枣仁饮片组,固体饮料低、中、高剂量组小鼠睡眠时间分别延长了40.42%、42.63%、54.09%、53.55%,均具有统计学差异(P<0.001),说明一定剂量的固体饮料与戊巴比妥钠具有协同作用,可以极显著的延长小鼠睡眠时间,固体饮料优于单方酸枣仁饮片组。
表1固体饮料对戊巴比妥钠睡眠时间的影响
注:与空白对照组比较***P<0.001。
6.5戊巴比妥钠阈下剂量催眠实验
末次给予受试药物前12h禁食不禁水,末次灌胃30min后,各组动物给予30mg/kg·bw戊巴比妥钠,注射量为0.1mL/10g·bw,以小鼠的翻正反射消失达60s以上为入睡判断标准,记录30min内各组入睡动物数并计算睡眠发生率,睡眠发生率(%)=(入睡动物数/每组动物数)×100%。
固体饮料对戊巴比妥钠阈下剂量小鼠入睡发生率的影响见表2。由表2可以看出空白对照组的睡眠发生率为10%,固体饮料低、中、高剂量的睡眠发生率分别为90%、80%和100%;与空白对照组相比,经过固体饮料干预后,小鼠的睡眠发生率显著增加(P<0.001)。以上结果表明,固体饮料和酸枣仁饮片组增加小鼠睡眠发生率作用趋势为固体饮料高剂量(19.5g/kg)>低剂量(6.5g/kg)>中剂量(13g/kg)>酸枣仁饮片(5g/kg)。
表2固体饮料对巴比妥钠阈下剂量小鼠入睡发生率的影响
注:与空白对照组比较***P<0.001。
6.6巴比妥钠睡眠潜伏期实验
末次给予受试药物前12h禁食不禁水,末次灌胃20min后,各组动物按280mg/kg·bw给予巴比妥钠,注射量为0.1mL/10g·bw,以小鼠翻正反射消失60s以上为入睡判断标准,从注射巴比妥钠到动物入睡为睡眠潜伏期,观察各组受试物能否缩短巴比妥钠睡眠潜伏期。
睡眠潜伏期即小鼠注射巴比妥钠至翻正反射消失之间的时间,睡眠潜伏期越短说明样品促进睡眠效果越好。固体饮料对巴比妥钠睡眠潜伏期的影响见表3。由表3可以看出,空白对照组的睡眠潜伏期是(41.24±4.646)min,酸枣仁饮片,固体饮料低、中、高剂量组(6.5、13、19.5g/kg bw)的睡眠潜伏期分别为(30.12±8.129)、(28.18±11.508)、(19.31±4.240)、(24.46±6.195)min,与空白对照组相比,酸枣仁饮片以及固体饮料各个剂量均显著缩短了睡眠潜伏期(P<0.001),实验结果表明,固体饮料促进小鼠睡眠作用良好,其中固体饮料中剂量促进入睡效果最好,且固体饮料优于单方酸枣仁饮片组。
表3固体饮料对巴比妥钠睡眠潜伏期的影响(剔除数据)
注:与空白对照组比较***P<0.001。
在本实验条件及设计的剂量下,本组合物能显著延长戊巴比妥钠睡眠时间、增加戊巴比妥钠阈下剂量催眠试验入睡率和缩短巴比妥钠睡眠潜伏时间,无直接睡眠作用。根据《保健食品检验与评价技术规范实施手册》改善睡眠评价方法表明固体饮料各个剂量组均有明显的促睡眠作用,与戊巴比妥钠具有较好的协同作用,综上所述,本发明具有改善睡眠功效。
以上实施例中,各组分可通过常规工艺可制成片剂、口服液、颗粒剂、袋泡茶、药膏以及压片糖果、饼干、饮料类食品。
以上所述仅为本发明的具体实施方式,但本发明的保护范围并不局限于此,任何熟悉本领域的技术人员在本发明所揭露的技术范围内,可不经过创造性劳动想到的变化或替换,都应涵盖在本发明的保护范围之内。因此,本发明的保护范围应该以权利要求书所限定的保护范围为准。
Claims (4)
1.一种具有改善睡眠作用的组合物,其特征在于:所述的组合物各成分重量配比为酸枣仁1-24份,茯苓1-24份,远志1-12份,丹参1-24份,三七茎叶1-12份。
2.根据权利要求1所述的具有改善睡眠作用的组合物,其特征在于:所述的组合物中各成分重量配比为酸枣仁3-18份,茯苓3-18份,远志2-6份,丹参3-18份,三七茎叶2-6份。
3.根据权利要求1所述的具有改善睡眠作用的组合物,其特征在于:所述的组合物可制成颗粒剂、胶囊剂、片剂、口服液、药膏以及压片糖果、饮料类食品。
4.根据权利要求1-3任一项所述的具有改善睡眠作用的组合物,其特征在于:该组合物在制备具有改善睡眠功能的药物组合物中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111623830.6A CN114190551A (zh) | 2021-12-28 | 2021-12-28 | 一种具有改善睡眠作用的组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111623830.6A CN114190551A (zh) | 2021-12-28 | 2021-12-28 | 一种具有改善睡眠作用的组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114190551A true CN114190551A (zh) | 2022-03-18 |
Family
ID=80657008
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111623830.6A Pending CN114190551A (zh) | 2021-12-28 | 2021-12-28 | 一种具有改善睡眠作用的组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114190551A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118416189A (zh) * | 2024-06-21 | 2024-08-02 | 云南省药物研究所 | 一种药食同源组合物及其制备方法与应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102397351A (zh) * | 2010-09-10 | 2012-04-04 | 北京润德康医药技术有限公司 | 一种治疗失眠的中药组合物 |
CN103169787A (zh) * | 2012-11-30 | 2013-06-26 | 云南白药天颐茶品有限公司 | 一种具有提高睡眠质量延长深度睡眠时间的组合物及其应用 |
CN104069335A (zh) * | 2014-07-17 | 2014-10-01 | 江苏东博生物医药有限公司 | 一种改善睡眠的药物组合物及制备方法和应用 |
-
2021
- 2021-12-28 CN CN202111623830.6A patent/CN114190551A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102397351A (zh) * | 2010-09-10 | 2012-04-04 | 北京润德康医药技术有限公司 | 一种治疗失眠的中药组合物 |
CN103169787A (zh) * | 2012-11-30 | 2013-06-26 | 云南白药天颐茶品有限公司 | 一种具有提高睡眠质量延长深度睡眠时间的组合物及其应用 |
CN104069335A (zh) * | 2014-07-17 | 2014-10-01 | 江苏东博生物医药有限公司 | 一种改善睡眠的药物组合物及制备方法和应用 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118416189A (zh) * | 2024-06-21 | 2024-08-02 | 云南省药物研究所 | 一种药食同源组合物及其制备方法与应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102526474B (zh) | 一种治疗神经衰弱的中药组合物 | |
CN104069335A (zh) | 一种改善睡眠的药物组合物及制备方法和应用 | |
CN100394951C (zh) | 治疗失眠的药物及其制备方法 | |
CN112294924A (zh) | 一种养心安神药物组合物及其制备方法和应用 | |
CN103142873A (zh) | 一种治疗顽固性失眠的中药 | |
CN114190551A (zh) | 一种具有改善睡眠作用的组合物 | |
CN101700336B (zh) | 一种治疗颅脑外伤后遗性头痛的中药制剂及其制备方法 | |
CN103181949A (zh) | 一种镇静安神口服制剂及其制备方法 | |
CN108355088A (zh) | 一种改善睡眠质量的酸枣仁药酒及其制备方法 | |
CN100502918C (zh) | 一种用于治疗失眠的药剂及其制备方法 | |
CN103977281A (zh) | 一种治疗女性内分泌失调的中药组合物及其制备方法 | |
CN104938727A (zh) | 一种抗失眠代用茶的制备方法 | |
CN110960632B (zh) | 一种改善睡眠产品的配方及其制备方法 | |
CN100360152C (zh) | 一种治疗失眠症的药物组合物及其制备方法 | |
CN103393938B (zh) | 一种降血糖的中药组合物 | |
CN103028034A (zh) | 一种治疗失眠症的药物组合物及其制备方法 | |
CN107137504B (zh) | 一种改善睡眠、增强免疫力的保健食品 | |
CN112316066A (zh) | 一种含茉莉花的安神助眠中药配方红糖及其制备方法 | |
CN114081171A (zh) | 一种具有辅助改善睡眠作用的功能性食品组合物 | |
CN105535587A (zh) | 一种治疗心肾不交型心悸失眠的中药制剂及其制备方法 | |
CN103845447B (zh) | 一种具有益气健脾养肝、养血养心安神功能的纯中药养生制剂 | |
CN112439038A (zh) | 一种快速改善睡眠的药物 | |
CN115814011B (zh) | 一种清心助眠益智药枕及其制备方法 | |
CN116549595B (zh) | 一种治疗儿童功能性消化不良的药物组合物及其制剂和应用 | |
CN113855754B (zh) | 一种祛瘀止血的中药组合物及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220318 |
|
RJ01 | Rejection of invention patent application after publication |